{"meta":{"status":200,"messages":[],"pagination":{"max":1,"offset":0,"count":1,"total":1,"pageNum":1,"totalPages":1,"sort":null,"currentUrl":"https://api.digitalmedia.hhs.gov/api/v2/resources/media.json?offset=0&max=1&ignoreHiddenMedia=1&format=json&id=11168&newUrlBase=http://www.cdc.gov/transplantsafety/outbreak-invest","nextUrl":null,"previousUrl":null}},"results":[{"content":"
\nTransplant Safety: Recognizing Donor-Derived InfectionsExternalExternal
\nTransplant transmitted infections are very rare. They are suspected in about 1% of transplants and confirmed in far fewer (Kaul, et al).
\nTransplant Safety: Recognizing Donor-Derived Infections Microsporidiosis is an emerging transplant-associated infection, and CDC depends on astute clinicians to recognize the signs of this and other donor-derived diseases. February 2014
\nRebecca J. Free, Pallavi Annambhotla, Ricardo M. La Hoz, Lara Danziger-Isakov, Jefferson M. Jones, Lijuan Wang, Senthil Sankthivel, Marilyn E. Levi, Marian G. Michaels, Wendi Kuhnert, David Klassen, Sridhar V. Basavaraju, Ian T. Kracalik, Risk of SARS-CoV-2 transmission through solid organ transplantation and outcomes of COVID-19 among recent transplant recipients, Open Forum Infectious Diseases, 2022;, ofac221, https://doi.org/10.1093/ofid/ofac221
Kaul DR, Vece G, Blumberg E, La Hoz RM, Ison MG, Green M, Pruett T, Nalesnik MA, Tlusty SM, Wilk AR, Wolfe CR, Michaels MG. Ten years of donor-derived disease: A report of the disease transmission advisory committee. Am J Transplant. 2021 Feb;21(2):689-702. doi: 10.1111/ajt.16178. Epub 2020 Jul 25. PMID: 32627325.
\n